20 Facts About Allison McGeer

Allison Joan McGeer was born on 1953 and is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto.

Allison McGeer appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases.

Allison McGeer trained in internal medicine and infectious diseases at the University of Toronto.

From 1989 to 1990, Allison McGeer was a clinical fellow in hospital epidemiology at Yale New Haven Hospital.

In 1989, Allison McGeer joined the Sinai Health System, where she specialised in microbiology.

Related searches

Allison McGeer holds a joint position as Professor in the Department of Laboratory Medicine and Pathobiology and of Infectious Diseases at the Dalla Lana School of Public Health.

Allison McGeer has studied the impact of influenza on hospital staff.

Allison McGeer encouraged people of all ages to receive the universal flu vaccine and supported hospitals in improving their influenza testing.

Allison McGeer contributed to a review of influenza diagnosis among older hospitalized patients on behalf of the Canadian Immunization Research Network Serious Outcomes Surveillance Network.

Allison McGeer is the director of infection control, and works as a microbiologist and infectious disease consultant at the Mount Sinai Hospital.

Allison McGeer has received research grants from Pfizer and Seqirus, as well as personal and consulting fees from AstraZeneca, GlaxoSmithKline, Janssen, Medicago, Merck, Moderna, and Sanofi Pasteur.

Allison McGeer led the investigations into Severe Acute Respiratory Syndrome in Toronto.

Allison McGeer was based at the Ontario SARS emergency operation centre.

Allison McGeer believes that Toronto eliminated SARS by isolating people who were infected or at risk from the virus, preventing its spread.

Allison McGeer serves on Canada's COVID-19 Expert Panel, assembled by Chief Science Advisor of Canada Dr Mona Nemer to assist in providing advice and guidance to Prime Minister Justin Trudeau and the federal government.

In late January 2020, Allison McGeer expressed concerns over the ability to contain SARS-CoV-2, particularly the unknown incubation period, which makes it difficult to track and quarantine people who have been exposed.

Allison McGeer started to investigate how long SARS-CoV-2 can survive in air in March 2020.

Allison McGeer served as a principal investigator on a study examining the association between frailty and outcomes of COVID-19 infection.

In May 2021, Allison McGeer explained that National Advisory Committee on Immunization deliberations to approve COVID-19 vaccines couldn't be made available to the public because the agency "has nothing like the budget or staff that would be needed" to do so.

Allison McGeer was recruited as a member of the newly formed Ontario Immunization Advisory Committee, created by Chief Medical Officer of Health Kieran Moore in August 2021 to work on provincial vaccine programs.